-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TR-4 in Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TR-4 in Asthma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TR-4 in Asthma Drug Details: TR-4 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ceclazepide in Helicobacter pylori Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ceclazepide in Helicobacter pylori Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ceclazepide in Helicobacter pylori Infections Drug Details: Ceclazepide (TR-2A) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TR-4 in Congestive Heart Failure (Heart Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TR-4 in Congestive Heart Failure (Heart Failure) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TR-4 in Congestive Heart Failure (Heart Failure) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-217 in Neuroendocrine Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PT-217 in Neuroendocrine Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-217 in Neuroendocrine Cancer Drug Details: PT-217 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-217 in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PT-217 in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-217 in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drug Details: PT-217 is...
-
Product Insights
NewGastritis – Drugs In Development, 2024
Empower your strategies with our Gastritis – Drugs In Development, 2024 report and make more profitable business decisions. Gastritis is characterized by inflammation or swelling of the lining of the stomach. Acute gastritis lasts for a short period of time while chronic gastritis lasts for a long period of time (months to years). Gastritis can be caused by medications such as ibuprofen, aspirin, or naproxen on long periods of consumption; excess intake of alcohol; Helicobacter pylori infection; certain autoimmune disorders; bile...
-
Product Insights
NewHelicobacter pylori Infections – Drugs In Development, 2024
Empower your strategies with our Helicobacter pylori Infections – Drugs In Development, 2024 report and make more profitable business decisions. Helicobacter pylori (H. pylori) infection occurs when the Helicobacter pylori (H. pylori) bacteria infect the stomach, typically during childhood. A leading cause of stomach ulcers, this infection is asymptomatic for many, with over half of the global population potentially affected. Recognition often arises when peptic ulcer symptoms manifest, prompting healthcare providers to test for H. pylori. Peptic ulcers, affecting the stomach...
-
Product Insights
NewReflux Esophagitis (Gastroesophageal Reflux Disease) – Drugs In Development, 2024
Empower your strategies with our Reflux Esophagitis (Gastroesophageal Reflux Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Gastroesophageal reflux disease (GERD) refers to a condition where the liquid content of the stomach refluxes into the esophagus. It is a chronic condition. The symptoms of GERD are nausea, heartburn, and vomiting. The predisposing factors include eating large meals, which can cause the lower esophageal sphincter (LES) to open inappropriately, as well as obesity, pregnancy, greasy food, and...
-
Product Insights
NewBlood Glucose Meters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
A blood glucose meter is an electronic diabetic management device used for measuring blood glucose levels. GlobalData's Medical Devices sector report, “Blood Glucose Meters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Blood Glucose Meters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Blood Glucose Meters report provides key information...